prazosin has been researched along with Respiratory Distress Syndrome in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yu, Z | 1 |
Saito, H | 1 |
Otsuka, H | 1 |
Shikama, Y | 1 |
Funayama, H | 1 |
Sakai, M | 1 |
Murai, S | 1 |
Nakamura, M | 1 |
Yokochi, T | 1 |
Takada, H | 1 |
Sugawara, S | 1 |
Endo, Y | 1 |
1 other study available for prazosin and Respiratory Distress Syndrome
Article | Year |
---|---|
Pulmonary platelet accumulation induced by catecholamines: Its involvement in lipopolysaccharide-induced anaphylaxis-like shock.
Topics: Anaphylaxis; Animals; Blood Platelets; Catecholamines; Cells, Cultured; Complement C5; Humans; Lipop | 2017 |